Analysis results revealed racial and sex disparities among patients with hypertrophic cardiomyopathy who receive implantable cardioverter-defibrillator (ICD) devices.

The risk-factor threshold for considering a patient with hypertrophic cardiomyopathy for a primary-prevention implantable defibrillator can be lower than sometimes occurs in practice, according to ...

Healio and Cardiology Today have compiled a list of the most-read cardiology news of October 2023.Readers were most interested in the FDA approval of a extravascular ICD system with anti ...

Thus, the authors concluded that the ESC hypertrophic cardiomyopathy-sudden cardiac death model provides accurate prognostic information which can be used to target ICD therapy in patients at the ...

However, accurately selecting which HCM patients need this ICD device, which is implanted in the patient for their lifetime, has been challenging, and which methods to use have been debatable.

In patients with cardiovascular disease who had an ICD and were at high risk for ventricular arrhythmias, increasing potassium levels led to a significantly lower risk for arrhythmia events.

A large study conducted across North America, Europe, the Middle East and Asia has validated the ESC recommendations for predicting and preventing sudden cardiac death (SCD) in patients with ...

Heart murmurs are surprisingly common. Around 10 percent of adults and 40–50 percent of children have them, and Yale Medicine ...

Ventricular Arrhythmias: Which Patients Benefit Most From an ICD? —A dozen researchers at 2 U.S. universities recently examined outcomes among ischemic versus non-ischemic cardiomyopathy ...